Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: HIV Ther. 2009 Sep 1;3(5):447–465. doi: 10.2217/hiv.09.30

Table 1. HIV-1 drug-resistance mutation lists.

ANRS IAS REGA STAN SDRM
Nucleoside reverse-transcriptase inhibitors mutations*
M41 L L L L L
E44 D A/D
A62 V
K65 R R N/R N/R R
D67 N N G/N/del N E/N/G
T69 D/N/S/i i A/N/D/G/i i D/i
K70 R E/R E/G/R E/G/R E/R
L74 I/V V I/V I/V I/V
V75 A/M/S/T I A/I/M/S/T I/M/T A/M/S/T
F77 L L L L
Y115 F F F F F
F116 Y Y Y Y
V118 I
Q151 M M M M M
M184 I/V I/V I/V I/V I/V
L210 W W W W W
T215 Mul F/Y Mul F/Y C/D/E/F/I/S/V/Y
K219 E/Q E/Q E/H/N/R/Q E/Q E/N/R/Q
Non-nucleoside reverse-transcriptase inhibitors mutations*
V90 I I I
A98 G/S§ G G G
L100 I I I I I
K101 E/P E/H/P E/H/N/P/Q E/P E/P
K103 H/N/S/T N H/N/R/S/T N/S N/S
V106 A/I/M A/I/M A/I/M A/M A/M
V108 I I I
E138 A K/Q
V179 D/F D/F/T D/E D/E/F F
Y181 C/I/V C/I/V C/I/V C/I/V C/I/V
Y188 C/L/H C/L/H C/L/H C/L/H C/L/H
G190 Mul A/S Mul A/E/S A/E/S
H221 Y
P225 H H H H H
F227 C/L C/L
M230 L L I/L L L
P236 L L
K238 N/T T
Y318 F
Protease inhibitors mutations*
L10 F/I/M/R/V C/F/I/R/V I/F/V/Y
V11 I I I/L
I13 V
I15 A/V
G16 E E
K20 I/M/R/T I/M/R/T/V I/M/R/T/V
L23 I I I
L24 I I F/I I I
D30 N N N N N
V32 I I I/L I I
L33 F/I/V F/I/V F/I/M/V F
E34 Q V
E35 G G/N
M36 I/L/V I/L/V
L38 W
R41 I/T
K43 T R/T
K45 I
M46 I/L I/L I/L I/L I/L
I47 A/V A/V A/V A/V A/V
G48 V V A/M/V M/V M/V
I50 L/V L/V L/V L/V L/V
F53 L/W/Y L/Y L L L/Y
I54 A/L/M/S/T/V A/L/M/S/T/V A/C/L/M/S/T/V A/L/M/T/V A/L/M/S/T/V
Q58 E E E -
D60 E E
I62 V V V
L63 P P
I64 L/M/V M/V
I66 F
H69 I/K/N/Q/R/Y K
K70 E
A71 I/L/T/V I/L/T/V I/L/T/V
G73 A/S/T A/C/S/T A/C/F/S/T/V S/T A/C/S/T
T74 P P A/E/S/P
L76 V V V V V
V77 I I A/T/V
V82 A/C/G/F/M/S/T A/F/L/I/S/T A/F/L/M/S/T A/F/L/S/T A/C/F/L/M/S/T
N83 D D D
I84 A/V V A/C/V A/C/V A/C/V
I85 V V V V
N88 D/S D/S D/S D/S D/S
L89 I/M/R/T/V V I/T/V
L90 M M M M M
I93 L/M M
C95 F - -

Positions in bold have mutations that appear in all five lists.

*

Wild-type amino acid (for consensus subtype B sequence) and reverse transcriptase or protease position.

ANRS: T215A/C/D/E/F/G/H/I/L/N/S/V/Y.

§

For subtype C only.

ANRS: G190A/C/E/Q/S/T/V.

–: Mutation not on list; A: Alanine; ANRS: The French National Agency for AIDS Research, v17 [302]; C: Cysteine; D: Aspartic acid; del: Deletion; E: Glutamic acid; F: Phenylalanine; G: Glycine; H: Histidine; i: Insertion; I: Isoleucine; IAS: International AIDS Society–USA; K: Lysine; L: Leucine; M: Methionine; Mul: Multiple mutations; N: Asparagine; P: Proline; Q: Glutamine; R: Arginine; REGA: Rega Institute mutation list [304]; S: Serine; SDRM: Surveillance drug-resistance mutation list; STAN: Stanford University HIV Drug Resistance Database [303]; T: Threonine; V: Valine; W: Tryptophan; Y: Tyrosine.